Qube Research & Technologies Ltd - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 4 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$12
+9.1%
40.0%0.00%
Q3 2023$11
-100.0%
4
-100.0%
0.00%
Q3 2022$23,000
-32.4%
11,796
+4.6%
0.00%
Q2 2022$34,000
-90.2%
11,274
-30.3%
0.00%
-100.0%
Q2 2021$346,00016,1680.00%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,459,572$4,058,2946.63%
Novo Holdings A/S 3,940,413$6,501,6810.41%
Newtyn Management, LLC 1,020,000$1,683,0000.35%
Avidity Partners Management LP 1,795,800$2,963,0700.06%
CAAS CAPITAL MANAGEMENT LP 459,779$758,6360.05%
Baker Brothers Advisors 2,492,118$4,111,9950.02%
RBF Capital, LLC 151,282$250,0000.02%
Cannell Capital 19,684$32,4790.01%
Evercore Wealth Management, LLC 146,676$242,0150.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 119,584$197,3140.01%
View complete list of CYTEIR THERAPEUTICS INC shareholders